U
RCPI

UBS’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

UBS’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$20K Buy
2,805
+1,901
+210% +$18.8K ﹤0.01% 8048
2014
Q2 		$13K Buy
+904
New +$15.7K ﹤0.01% 8656

Other funds holding RCPI

GCM
Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return

UBS's RCPI Position: Q3 2014 in Review

UBS increased its ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) stake by 210% in Q3 2014, buying an estimated $18.8K and bringing the position to 2,805 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #8048.

UBS first reported a position in RCPI in Q2 2014 and has held it in 2 quarters since. 67 funds tracked by Wall St. Rank hold RCPI as of Q3 2014.

  • UBS held 2,805 shares of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) worth $20K as of Q3 2014.
  • UBS bought 1,901 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $18.8K.
  • ROCK CREEK PHARMACEUTICALS INC COM STK (DE) made up ﹤0.01% of UBS's portfolio in Q3 2014, its #8048 holding.
  • UBS first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and has held it in 2 quarters since.
  • 67 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.